Lionel D. Lewis - Concepedia

Author

Lionel D. Lewis

Dartmouth–Hitchcock Medical Center ORCID

Also Known As

A George, Ames, Matthew M., Bharti Garg, Kennedy, Erin B., L D Lewis, L LEWIS, L. D. Lewis, L. LEWIS, L. Lewis, L.D. Lewis

257

Publications

5.8K

Citations

H-Index

151

Concepts

All Affiliations

Dartmouth–Hitchcock Medical Center Dartmouth College Roswell Park Comprehensive Cancer Center Cotton (United States)Memorial Sloan Kettering Cancer Center

About

Lionel D. Lewis is an author at Dartmouth–Hitchcock Medical Center specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	44	2.3K
2	Health Sciences	6	6	271
3	Natural Sciences	5	5	262
4	Engineering	2	2	64
5	Nursing	1	1	19

Lionel D. Lewis

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study Hans J. Hammers, Elizabeth R. Plimack, Jeffrey R. Infante, Journal of Clinical Oncology Tyrosine Kinase InhibitorUrologyOncologyGenitourinary CancerMedicine	2017	502
Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin Anthony W. Tolcher, Alain C. Mita, Lionel D. Lewis, Journal of Clinical Oncology	2008	239
Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301 Antonius A. Miller, Daryl J. Murry, Kouros Owzar, Journal of Clinical Oncology	2009	207
Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu. Frank H. Valone, Peter A. Kaufman, Paul M. Guyre, Journal of Clinical Oncology	1995	183
Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy Camilo E. Fadul, Jan L. Fisher, Thomas H. Hampton, Journal of Immunotherapy ImmunologyImmunoeditingPathologyImmunotherapeuticsCd4 T Cell Responses	2011	174
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study Asim Amin, Elizabeth R. Plimack, Marc S. Ernstoff, Journal for ImmunoTherapy of Cancer	2018	173
Olsalazine and 6-mercaptopurine-related bone marrow suppression: A possible drug-drug interaction Lionel D. Lewis, Andrea Benin, Carol L. Szumlanski, Clinical Pharmacology & Therapeutics	1997	155
Effects of Food on the Relative Bioavailability of Lapatinib in Cancer Patients Kevin M. Koch, Nandi J. Reddy, Roger B. Cohen, Journal of Clinical Oncology	2009	138
Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma Peter Borchmann, Roland Schnell, Irene Fuss, Blood	2002	111
Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL‐2 inhibitor, in patients with non‐Hodgkin lymphoma Suresh Agarwal, Ahmed Hamed Salem, Alexey V. Danilov, British Journal of Clinical Pharmacology	2016	98

Page 1